Replies to post #241782 on Amarin Corp Plc (AMRN)

[CalMustang]

Cannot be 100% until it's brought up in trial. However, there are three options that I can think of:

1) Amarin's presentation
- Dated "January 14, 2020"
- Contained no new substantial information.
- Why would Amarin be submitting this as "evidence"?

2) DRL's presentation
- Dated "14th January 2020"
- Does not discuss EPA / Vascepa / financial numbers

3) Hikma's presentation
- Dated "January 2020" (matches docket)
- Discusses market share for their generic of Vascepa
- Discusses the trial

4) Other
- Can't think of any but maybe you can.

If I were a betting man, I would put the whole neighborhood on 3).